id	sid	eid	entity	type
dpc-5139	3	1	2025;15(2):5139 1	CARDINAL
dpc-5139	3	2	francesca falcinelli1	PERSON
dpc-5139	3	3	cantarini2	PERSON
dpc-5139	3	4	bruno frediani2	PERSON
dpc-5139	3	5	laura calabrese1,3	PERSON
dpc-5139	3	6	1	CARDINAL
dpc-5139	3	7	siena university hospital	ORG
dpc-5139	3	8	siena	GPE
dpc-5139	3	9	italy 2	ORG
dpc-5139	3	10	university of siena	ORG
dpc-5139	3	11	italy 3 institute of dermatology	ORG
dpc-5139	3	12	catholic university	ORG
dpc-5139	3	13	rome	GPE
dpc-5139	3	14	italy	GPE
dpc-5139	4	1	calabrese l. upadacitinib	PERSON
dpc-5139	6	1	2025;15(2):5139	CARDINAL
dpc-5139	7	1	https://doi.org/10.5826/	ORG
dpc-5139	7	2	december 2, 2024	DATE
dpc-5139	8	1	april 2025	DATE
dpc-5139	8	2	2025	CARDINAL
dpc-5139	9	1	https://creativecommons.org/licenses/by-nc/4.0/	ORG
dpc-5139	13	1	f.f.	GPE
dpc-5139	15	1	l.c.	PERSON
dpc-5139	16	1	p.r.	PERSON
dpc-5139	16	2	b.f.	GPE
dpc-5139	16	3	l.c.	PERSON
dpc-5139	17	1	francesca falcinelli	PERSON
dpc-5139	17	2	md; department	ORG
dpc-5139	17	3	university of siena le scotte hospital	ORG
dpc-5139	17	4	bracci 16,	DATE
dpc-5139	17	5	53100	DATE
dpc-5139	17	6	siena (italy	ORG
dpc-5139	18	1	0000-0002-3149-8695	CARDINAL
dpc-5139	20	1	urticarial vasculitis	PERSON
dpc-5139	20	2	leukocytoclastic vasculitis	ORG
dpc-5139	20	3	jak	GPE
dpc-5139	21	1	1	CARDINAL
dpc-5139	22	1	77-year-old	DATE
dpc-5139	22	2	about 15 years	DATE
dpc-5139	23	1	the years	DATE
dpc-5139	25	1	28	CARDINAL
dpc-5139	25	2	every other week	DATE
dpc-5139	26	1	three months	DATE
dpc-5139	26	2	adalimumab	PERSON
dpc-5139	27	1	1a	CARDINAL
dpc-5139	28	1	2	CARDINAL
dpc-5139	30	1	2025;15(2):5139	CARDINAL
dpc-5139	31	1	longer than 24 hours	TIME
dpc-5139	34	1	adalimumab	PERSON
dpc-5139	34	2	15 mg	TIME
dpc-5139	35	1	one month	DATE
dpc-5139	35	2	eight hours	TIME
dpc-5139	36	1	15 mg	QUANTITY
dpc-5139	36	2	three months	DATE
dpc-5139	36	3	1d	CARDINAL
dpc-5139	37	1	jak-1	ORG
dpc-5139	38	1	2	CARDINAL
dpc-5139	39	1	pan-jaki tofacitinib	PERSON
dpc-5139	39	2	one	CARDINAL
dpc-5139	39	3	3	CARDINAL
dpc-5139	39	4	one	CARDINAL
dpc-5139	39	5	4	CARDINAL
dpc-5139	42	1	5	CARDINAL
dpc-5139	43	1	jak1/jak2	ORG
dpc-5139	43	2	1	CARDINAL
dpc-5139	45	1	three months	DATE
dpc-5139	47	1	2025;15(2):5139 3	CARDINAL
dpc-5139	47	2	6	CARDINAL
dpc-5139	50	1	1	CARDINAL
dpc-5139	50	2	marzano av	PERSON
dpc-5139	50	3	maronese	NORP
dpc-5139	51	1	urticarial vasculitis	PERSON
dpc-5139	52	1	clin immunol	PERSON
dpc-5139	53	1	1137-1149	DATE
dpc-5139	54	1	doi:10.1016	GPE
dpc-5139	55	1	pmid	PERSON
dpc-5139	55	2	35396080 2	DATE
dpc-5139	55	3	mohamed mf	PERSON
dpc-5139	55	4	bhatnagar s	PERSON
dpc-5139	55	5	parmentier jm	PERSON
dpc-5139	55	6	wung p. upadacitinib	ORG
dpc-5139	56	1	clin transl sci	ORG
dpc-5139	56	2	jan 2024;17(1):e13688	DATE
dpc-5139	57	1	doi:10.1111	ORG
dpc-5139	58	1	37984057 3	DATE
dpc-5139	58	2	mansouri p	ORG
dpc-5139	58	3	-chalangari k.	PERSON
dpc-5139	60	1	dec 2022;35(12):e15932	DATE
dpc-5139	60	2	doi:10.1111/dth.15932	ORG
dpc-5139	61	1	36226796 4	DATE
dpc-5139	62	1	zhu kj	PERSON
dpc-5139	62	2	yang pd	PERSON
dpc-5139	62	3	xu q. tofacitinib	PERSON
dpc-5139	64	1	2021;12:695768	ORDINAL
dpc-5139	64	2	doi:10.3389	ORG
dpc-5139	65	1	pmid	PERSON
dpc-5139	65	2	34248994 5	DATE
dpc-5139	66	1	rathore u	PERSON
dpc-5139	66	2	patro p	PERSON
dpc-5139	66	3	agarwal v	PERSON
dpc-5139	68	1	clin rheumatol	PERSON
dpc-5139	69	1	jan 2022;41(1):33-44	DATE
dpc-5139	70	1	021	CARDINAL
dpc-5139	71	1	34729652 6	DATE
dpc-5139	72	1	ogawa	PERSON
dpc-5139	72	2	fukaura	GPE
dpc-5139	72	3	janus kinase	PERSON
dpc-5139	73	1	j am	PERSON
dpc-5139	74	1	doi:10.1016/j.jaad.2023.10.056	ORG
dpc-5139	75	1	37924954	CARDINAL